Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.

Autor: Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Grover P; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio., Awosika J; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio., Gulati S; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio., Hsu CY; Vanderbilt University Medical Center, Nashville, Tennessee., Alimohamed SI; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina., Bashir B; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Berg S; Loyola University Medical Center, Maywood, Illinois., Bilen MA; Winship Cancer Institute, Emory University, Atlanta, Georgia., Bowles D; University of Colorado, Denver., Castellano C; Winship Cancer Institute, Emory University, Atlanta, Georgia., Desai A; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Elkrief A; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Eton OE; Hartford Healthcare Cancer Institute, Hartford, Connecticut., Fecher LA; University of Michigan Rogel Cancer Center, Ann Arbor., Flora D; St. Elizabeth Health Care, Edgewood, Kentucky., Galsky MD; Tisch Cancer Institute, Mount Sinai, New York., Gatti-Mays ME; Division of Medical Oncology, The Ohio State University, Columbus., Gesenhues A; St. Elizabeth Health Care, Edgewood, Kentucky., Glover MJ; Stanford University, Stanford, California., Gopalakrishnan D; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Gupta S; Cleveland Clinic, Cleveland, Ohio., Halfdanarson TR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Hayes-Lattin B; Knight Cancer Institute, Oregon Health and Science University, Portland., Hendawi M; Aurora Cancer Center, Advocate Aurora Health, Milwaukee, Wisconsin., Hsu E; Hartford Healthcare Cancer Institute, Hartford, Connecticut., Hwang C; Henry Ford Cancer Institute, Detroit, Michigan., Jandarov R; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio., Jani C; Mt. Auburn Hospital, Boston, Massachusetts., Johnson DB; Vanderbilt University Medical Center, Nashville, Tennessee., Joshi M; Penn State Cancer Institute, Hershey, Pennsylvania., Khan H; Brown University and Lifespan Cancer Institute, Providence, Rhode Island., Khan SA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York., Knox N; Loyola University Medical Center, Maywood, Illinois., Koshkin VS; UCSF, Helen Diller Comprehensive Cancer Center, San Francisco., Kulkarni AA; Masonic Cancer Center, University of Minnesota, Minneapolis., Kwon DH; UCSF, Helen Diller Comprehensive Cancer Center, San Francisco., Matar S; Hollings Cancer Center, MUSC, Charleston., McKay RR; Moores Cancer Center, UCSD, San Diego, California., Mishra S; Vanderbilt University Medical Center, Nashville, Tennessee., Moria FA; McGill University Health Centre, Montreal, Quebec, Canada., Nizam A; Cleveland Clinic, Cleveland, Ohio., Nock NL; Case Comprehensive Cancer Center, Department of Population and Quantitative Health Sciences, Cleveland, Ohio., Nonato TK; Moores Cancer Center, UCSD, San Diego, California., Panasci J; Jewish General Hospital, McGill University, Montreal, Quebec, Canada., Pomerantz L; Penn State Cancer Institute, Hershey, Pennsylvania., Portuguese AJ; Fred Hutchinson Cancer Research Center, Seattle, Washington., Provenzano D; George Washington University, Washington, DC., Puc M; Virtua Health, Marlton, New Jersey., Rao YJ; George Washington University, Washington, DC., Rhodes TD; Intermountain Healthcare, Salt Lake City, Utah., Riely GJ; Memorial Sloan Kettering Cancer Center, New York., Ripp JJ; University of Kansas Medical Center, Kansas City., Rivera AV; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Ruiz-Garcia E; Instituto Nacional de Cancerologia, Mexico., Schmidt AL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schoenfeld AJ; Memorial Sloan Kettering Cancer Center, New York., Schwartz GK; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York., Shah SA; Stanford University, Stanford, California., Shaya J; Moores Cancer Center, UCSD, San Diego, California., Subbiah S; Stanley S. Scott Cancer Center, LSU, New Orleans, Louisiana., Tachiki LM; Fred Hutchinson Cancer Research Center, Seattle, Washington., Tucker MD; Vanderbilt University Medical Center, Nashville, Tennessee., Valdez-Reyes M; Instituto Nacional de Cancerologia, Mexico., Weissmann LB; Mt. Auburn Hospital, Boston, Massachusetts., Wotman MT; Tisch Cancer Institute, Mount Sinai, New York., Wulff-Burchfield EM; University of Kansas Medical Center, Kansas City., Xie Z; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Yang YJ; Vanderbilt University Medical Center, Nashville, Tennessee., Thompson MA; Aurora Cancer Center, Advocate Aurora Health, Milwaukee, Wisconsin.; Tempus Labs, Chicago, Illinois., Shah DP; Mays Cancer Center, UT Health, San Antonio, Texas., Warner JL; Vanderbilt University Medical Center, Nashville, Tennessee., Shyr Y; Vanderbilt University Medical Center, Nashville, Tennessee., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wise-Draper TM; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio.

Publikováno v: JAMA oncology [JAMA Oncol] 2023 Jan 01; Vol. 9 (1), pp. 128-134.